2021
DOI: 10.1016/j.ahj.2021.04.011
|View full text |Cite
|
Sign up to set email alerts
|

Financial burden, distress, and toxicity in cardiovascular disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
35
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(35 citation statements)
references
References 79 publications
0
35
0
Order By: Relevance
“…Cost-sharing has resulted in patients shouldering a greater proportion of the financial burden related to medical care [ 2 – 4 ]. Treatment-related financial hardship is best described within cancer care due to an aging patient population and advances in costly therapies; however, a similar phenomenon has been observed in other areas of medical care, including among individuals with chronic health conditions [ 5 – 9 ]. Significant to catastrophic financial burden is associated with increased patient mortality and treatment non-adherence, as well as a notable decrease in quality of life [ 10 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…Cost-sharing has resulted in patients shouldering a greater proportion of the financial burden related to medical care [ 2 – 4 ]. Treatment-related financial hardship is best described within cancer care due to an aging patient population and advances in costly therapies; however, a similar phenomenon has been observed in other areas of medical care, including among individuals with chronic health conditions [ 5 – 9 ]. Significant to catastrophic financial burden is associated with increased patient mortality and treatment non-adherence, as well as a notable decrease in quality of life [ 10 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…Despite the growing recognition of the increasing economic burden of chronic liver disease globally, we lack a comprehensive understanding of its financial impact on patients and their families. While there has been an increasing recognition of the financial impact of cancer [ 5 ] and cardiovascular disease [ 6 ] on patients and their families, we currently lack an understanding of the costs experienced by patients with chronic liver disease and their families across the following domains: Financial burden: patient and family income consumed by health care costs [ 7–9 ] Financial distress: material, behavioral, and psychological consequences of financial burden [ 7–11 ] Financial toxicity: adverse health outcomes of financial distress [ 5,8,12 ] To address this gap, we performed a scoping review of the financial impact of chronic liver disease on patients and families to broadly explore key concepts and available evidence on this topic. [ 13 ] Our specific scoping review objectives were to (1) identify the types of financial burden and distress experienced by patients with chronic liver disease and their family caregivers; (2) identify risk factors for financial burden and distress; and (3) describe financial toxicity outcomes in this population.…”
Section: Introductionmentioning
confidence: 99%
“…HCWs who sustained the injury might develop stress, and this will affect the quality of their work, which might increase the chance of another sharp injury occurrence. If the HCWs contracted a blood-borne infection as a result of a sharp injury, they will need to begin treatment, and this will add to the country’s financial burden [ 10 , 11 ]. HCWs who become infected are more likely to take medical leave, hence reducing human resources.…”
Section: Introductionmentioning
confidence: 99%